Johnny Vercouillie

Dr. Johnny Vercouillie

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2008 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
MJMichelle L. James
Michelle L. James
RFRoger Fulton
Roger Fulton
JVJohnny Vercouillie
Johnny Vercouillie
DHDavid J. Henderson
David J. Henderson
LGLucette Garreau
Lucette Garreau
MKMichael Kassiou
Michael Kassiou
The translocator protein (18 kDa) (TSPO), formerly known as the peripheral benzodiazepine receptor, is dramatically upregulated under pathologic conditions. Activated microglia are the main cell type expressing the TSPO at sites of central nervous system pathology. Radioligands for the TSPO can therefore measure active disease in the brain. This article details the synthesis, radiofluorination, and pharmacologic evaluation of a new TSPO-specific pyrazolopyrimidine, DPA-714. Methods: The affinity of DPA-714 for the TSPO was measured in rat kidney membranes with 3H-PK11195. The in vitro functional activity of DPA-714 was measured in a steroidogenic assay in which the ability of DPA-714 to increase pregnenolone synthesis was measured with rat C6 glioma cells. The radiofluorination of DPA-714 was achieved by nucleophilic 18F-fluoride displacement of the tosylate precursor. 18F-DPA-714 was assessed in rats harboring unilateral quinolinic acid (QA) lesions. In addition, pretreatment experiments were performed with PK11195 (5 mg/kg), DPA-714 (1 mg/kg), and DPA-713 (1 mg/kg). The in vivo binding and biodistribution of 18F-DPA-714 were determined in a baboon with PET. Experiments involving presaturation with PK11195 (1.5 mg/kg) and displacement with DPA-714 (1 mg/kg) were conducted to evaluate the specificity of radioligand binding. Results: In vitro binding studies revealed that DPA-714 displayed a high affinity for the TSPO (dissociation constant, 7.0 nM). DPA-714 stimulated pregnenolone synthesis at levels 80% above the baseline. 18F-DPA-714 was prepared at a 16% radiochemical yield and a specific activity of 270 GBq/μmol. In rats harboring unilateral QA lesions, an 8-fold-higher level of uptake of 18F-DPA-714 was observed in the ipsilateral striatum than in the contralateral striatum. Uptake in the ipsilateral striatum was shown to be selective because it was inhibited to the level in the contralateral striatum in the presence of PK11195, nonlabeled DPA-714, or DPA-713. PET studies demonstrated rapid penetration and good retention of 18F-DPA-714 in the baboon brain. Pretreatment with PK11195 effectively inhibited the uptake of 18F-DPA-714 in the whole brain, indicating its selective binding to the TSPO. The injection of nonlabeled DPA-714 20 min after the injection of 18F-DPA-714 resulted in radioligand washout, demonstrating the reversibility of 18F-DPA-714 binding. Conclusion: 18F-DPA-714 is a specific radioligand for the TSPO, displaying promising in vivo properties and thus warranting further investigation.

18 January 2012 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
VCV. Camus
V. Camus
PPPierre Payoux
Pierre Payoux
LBL. Barré
L. Barré
BDB. Desgranges
B. Desgranges
TVT. Voisin
T. Voisin
DGD. Guilloteau
D. Guilloteau
Purpose Positron emission tomography (PET) imaging of brain amyloid load has been suggested as a core biomarker for Alzheimer’s disease (AD). The aim of this study was to test the feasibility of using PET imaging with 18F-AV-45 (florbetapir) in a routine clinical environment to differentiate between patients with mild to moderate AD and mild cognitive impairment (MCI) from normal healthy controls (HC). Methods In this study, 46 subjects (20 men and 26 women, mean age of 69.0 ± 7.6 years), including 13 with AD, 12 with MCI and 21 HC subjects, were enrolled from three academic memory clinics. PET images were acquired over a 10-min period 50 min after injection of florbetapir (mean ± SD of radioactivity injected, 259 ± 57 MBq). PET images were assessed visually by two individuals blinded to any clinical information and quantitatively via the standard uptake value ratio (SUVr) in the specific regions of interest, which were defined in relation to the cerebellum as the reference region. Results The mean values of SUVr were higher in AD patients (median 1.20, Q1-Q3 1.16-1.30) than in HC subjects (median 1.05, Q1-Q3 1.04-1.08; p = 0.0001) in the overall cortex and all cortical regions (precuneus, anterior and posterior cingulate, and frontal median, temporal, parietal and occipital cortex). The MCI subjects also showed a higher uptake of florbetapir in the posterior cingulate cortex (median 1.06, Q1-Q3 0.97-1.28) compared with HC subjects (median 0.95, Q1-Q3 0.82-1.02; p = 0.03). Qualitative visual assessment of the PET scans showed a sensitivity of 84.6% (95% CI 0.55–0.98) and a specificity of 38.1% (95% CI 0.18–0.62) for discriminating AD patients from HC subjects; however, the quantitative assessment of the global cortex SUVr showed a sensitivity of 92.3% and specificity of 90.5% with a cut-off value of 1.122 (area under the curve 0.894). Conclusion These preliminary results suggest that PET with florbetapir is a safe and suitable biomarker for AD that can be used routinely in a clinical environment. However, the low specificity of the visual PET scan assessment could be improved by the use of specific training and automatic or semiautomatic quantification tools.

1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MBMatthieu Bailly
Matthieu Bailly
CDChristophe Destrieux
Christophe Destrieux
CHCaroline Hommet
Caroline Hommet
KMKarl Mondon
Karl Mondon
JCJean-Philippe Cottier
Jean-Philippe Cottier
MRMaria-Joao Ribeiro
Maria-Joao Ribeiro
Objective.The objective of this study was to compare glucose metabolism and atrophy, in the precuneus and cingulate cortex, in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI), using FreeSurfer.Methods.47 individuals (17 patients with AD, 17 patients with amnestic MCI, and 13 healthy controls (HC)) were included. MRI and PET images using18F-FDG (mean injected dose of 185 MBq) were acquired and analyzed using FreeSurfer to define regions of interest in the hippocampus, amygdala, precuneus, and anterior and posterior cingulate cortex. Regional volumes were generated. PET images were registered to the T1-weighted MRI images and regional uptake normalized by cerebellum uptake (SUVr) was measured.Results.Mean posterior cingulate volume was reduced in MCI and AD. SUVr were different between the three groups: mean precuneus SUVr was 1.02 for AD, 1.09 for MCI, and 1.26 for controls (p<0.05); mean posterior cingulate SUVr was 0.96, 1.06, and 1.22 for AD, MCI, and controls, respectively (p<0.05).Conclusion.We found graduated hypometabolism in the posterior cingulate cortex and the precuneus in prodromal AD (MCI) and AD, whereas atrophy was not significant. This suggests that the use of18F-FDG in these two regions could be a neurodegenerative biomarker.

1 May 2012 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
NANicolas & Neuropsychiatry Arlicot
Nicolas & Neuropsychiatry Arlicot
JVJohnny Vercouillie
Johnny Vercouillie
MRMaria-João Ribeiro
Maria-João Ribeiro
CTClovis Tauber
Clovis Tauber
YVYann Venel
Yann Venel
DGDenis Guilloteau
Denis Guilloteau

2 November 2001 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
JTJari Tarkiainen
Jari Tarkiainen
JVJohnny Vercouillie
Johnny Vercouillie
PEPatrick Emond
Patrick Emond
JSJohan Sandell
Johan Sandell
JHJukka Hiltunen
Jukka Hiltunen
CHChrister Halldin
Christer Halldin

1 September 2005 in Synapse
Verified
Journal Article
Closed access
PDF file
CHChrister Halldin
Christer Halldin
JLJohan Lundberg
Johan Lundberg
JSJudit Sóvágó
Judit Sóvágó
BGBalázs Gulyás
Balázs Gulyás
DGDenis Guilloteau
Denis Guilloteau
LFLars Farde
Lars Farde